TMO — Thermo Fisher Scientific Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual balance sheet for Thermo Fisher Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,353	4,477	8,524	8,077	5,570
Net Total Accounts Receivable
Net Total Receivables	6,472	8,945	9,427	9,664	9,626
Total Inventory
Total Other Current Assets
Total Current Assets	21,957	20,113	25,229	24,589	22,137
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,687	9,864	10,873	11,004	10,795
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	69,052	95,123	97,154	98,726	97,321
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,304	13,436	17,010	14,012	13,332
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	34,545	54,330	53,176	51,991	47,737
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	34,507	40,793	43,978	46,735	49,584
Total Liabilities & Shareholders' Equity	69,052	95,123	97,154	98,726	97,321
Total Common Shares Outstanding